Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465731) titled 'A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine' on March 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition:
Healthy Volunteers
Intervention:
Drug: Centanafadine SR
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 27, 2022
Target Sample Size: 62
Countries of Recruitment:
United States
To know ...